Lynn C. Hartmann

Atypical Hyperplasia of the Breast — Risk Assessment and Management Options

Lynn C. Hartmann, Amy C. Degnim, Richard J. Santen et al. · New England Journal of Medicine · 2014 · 363 citations · Full text

Medicine, Oncology, Pathology +17

Human epithelial ovarian cancer allelotype.

William A. Cliby, S Ritland, Lynn C. Hartmann et al. · PubMed · 1993 · 242 citations

Life Sciences, Genetics, Oncology +11

Metformin attenuates ovarian cancer cell growth in an AMP‐kinase dispensable manner

Ramandeep Rattan, Shailendra Giri, Lynn C. Hartmann et al. · Journal of Cellular and Molecular Medicine · 2009 · 224 citations · Full text

Medicine, Oncology, Pharmacology +17

Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.

Mark K. Dodson, Lynn C. Hartmann, William A. Cliby et al. · PubMed · 1993 · 97 citations

Medicine, Genetics, Oncology +17

Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer.

Viji Shridhar, Keith C. Bible, Julie Staub et al. · PubMed · 2001 · 91 citations

Life Sciences, Molecular Biology, Oncology +11